Migraine in pregnancy

Seminars in Neurology

Volumn 27, Issue 5, 2007, Pages 425-433

  Loder, Elizabeth ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Lactation; Migraine; Postpartum; Pregnancy

Indexed keywords

ACETYLSALICYLIC ACID; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BUTALBITAL; CHLORPROMAZINE; CLOMIFENE; COCODAMOL; CODEINE; CORTICOSTEROID; DEXAMETHASONE; ERGOTAMINE; FOLIC ACID; HERBACEOUS AGENT; IBUPROFEN; MAGNESIUM; METHYSERGIDE; METOCLOPRAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; ONDANSETRON; PARACETAMOL; PHENOTHIAZINE DERIVATIVE; PREDNISONE; PROCHLORPERAZINE; PROMETHAZINE; PROPRANOLOL; PYRIDOXINE; SUMATRIPTAN; TRIMETHOBENZAMIDE; UNINDEXED DRUG; VALPROATE SEMISODIUM;

BIRTH DEFECT; BREAST FEEDING; DECISION MAKING; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DEPENDENCE; DUCTUS ARTERIOSUS OBLITERATION; FETAL HEMORRHAGE; HEADACHE; HUMAN; INTRAUTERINE GROWTH RETARDATION; LACTATION; MIGRAINE; NAUSEA; NONHUMAN; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; PUERPERIUM; REVIEW; RISK ASSESSMENT; RISK FACTOR; TREATMENT INDICATION; TREATMENT RESPONSE; WITHDRAWAL SYNDROME;

FEMALE; HUMANS; MIGRAINE DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 35649028338     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-991121     Document Type: Review

References (82)

1. Lipton RB, Bigal ME. The epidemiology of migraine. Am J Med 2005;118(suppl 1):3S-10S
2. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American migraine study II. Headache 2001; 41:646-657
3. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-1835
4. Alsdorf R, Wyszynski DF. Teratogenicity of sodium valproate. Expert Opin Drug Saf 2005;4:345-353
5. Amir BY, Yaacov B, Guy B, Gad P, Itzhak W, Gal I. Headaches in women undergoing in vitro fertilization and embryo-transfer treatment. Headache 2005;45:215-219
6. Parra J, Brocalero-Camacho A, Sancho J, Cervelló-Donderis A, Lacruz-Ballester L, Romero-Martínez A. Migrainous infarction and clomiphene citrate. Rev Neurol 2006;42:572-574
7. Ertresvag JM, Zwart JA, Helde G, Johnsen HJ, Bovim G. Headache and transient focal neurological symptoms during pregnancy, a prospective cohort. Acta Neurol Scand 2005; 111:233-237
8. Mannix LK, Diamond M, Loder E. Women and headache: a treatment approach based on life stages. Cleve Clin J Med 2002;69:488-500
9. Wainscott G, Sullivan FM, Volans GN, Wilkinson M. The outcome of pregnancy in women suffering from migraine. Postgrad Med J 1978;54:98-102
10. Olesen C, Steffensen FH, Sorensen HT, Nielsen GL, Olsen J. Pregnancy outcome following prescription for sumatriptan. Headache 2000;40:20-24
11. Banhidy F, Acs N, Horvath-Puho E, Czeizel AE. Maternal severe migraine and risk of congenital limb deficiencies. Birth Defects Res A Clin Mol Teratol 2006; 76:592-601
12. Banhidy F, Acs N, Horvath-Puho E, Czeizel AE. Pregnancy complications and delivery outcomes in pregnant women with severe migraine. Eur J Obstet Gynecol Reprod Biol 2006; November 8 (Epub ahead of print)
13. Noris M, Perico N, Remuzzi G. Mechanisms of disease: pre-eclampsia. Nat Clin Pract Nephrol 2005;1:98-114
14. Adeney KL, Williams MA. Migraine headaches and preeclampsia: an epidemiologic review. Headache 2006;46: 794-803
15. Adeney KL, Williams MA, Miller RS, Frederick IO, Sorensen TK, Luthy DA. Risk of preeclampsia in relation to maternal history of migraine headaches. J Matern Fetal Neonatal Med 2005;18:167-172
16. Facchinetti F, Allais G, D'Amico R, et al. The relationship between headache and preeclampsia: a case-control study. Eur J Obstet Gynecol Reprod Biol 2005;121:143-148
17. Marcoux S, Beruhe S, Brisson J, Fabia J. History of migraine and risk of pregnancy-induced hypertension. Epidemiology 1992;3:53-56
18. Rubin PC, McCabe R. Postpartum migraine and severe preeclampsia. Lancet 1984;2:285-286
19. Moore MP, Redman CW. Case-control study of severe preeclampsia of early onset. Br Med J (Clin Res Ed) 1983;287: 580-583
20. Scher AI, Terwindt GM, Picavet HS, Verschuren WM, Ferrari MD, Launer LJ. Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 2005;64:614-620
21. Chames MC, Livingston JC, Ivester TS, Barton JR, Sibai BM. Late postpartum eclampsia: a preventable disease? Am J Obstet Gynecol 2002;186:1174-1177
22. Veltkamp R, Kupsch A, Polasek J, Yousry TA, Pfister HW. Late onset postpartum eclampsia without pre-eclamptic prodromi: clinical and neuroradiological presentation in two patients. J Neurol Neurosurg Psychiatry 2000;69:824-827
23. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders. 2nd ed. Cephalalgia 2004;24(suppl 1):9-160
24. Altman D, Carroll G, Duley L, et al. Do women with preeclampsia, and their babies, benefit from magnesium sulphate? The magpie trial: a randomised placebo-controlled trial. Lancet 2002;359:1877-1890
25. Rozen TD. Aborting a prolonged migrainous aura with intravenous prochlorperazine and magnesium sulfate. Headache 2003;43:901-903
26. Welch KM, Ramadan NM. Mitochondria, magnesium and migraine. J Neurol Sci 1995;134:9-14
27. Seelig MS. Interrelationship of magnesium and estrogen in cardiovascular and bone disorders, eclampsia, migraine and premenstrual syndrome. J Am Coll Nutr 1993;12:442-458
28. Ramadan NM, Halvorson H, Vande-Linde A, Levine SR, Helpern JA, Welch KM. Low brain magnesium in migraine. Headache 1989;29:590-593
29. Kittner SJ, Stern BJ, Feeser BR, et al. Pregnancy and the risk of stroke. N Engl J Med 1996;335:768-774
30. James AH, Bushneil CD, Jamison MG, Myers ER. Incidence and risk factors for stroke in pregnancy and the Puerperium. Obstet Gynecol 2005;106:509-516
31. Witlin AG, Mattar F, Sibai BM. Postpartum stroke: a twenty-year experience. Am J Obstet Gynecol 2000;183:83-88
32. Somerville BW. Estrogen-withdrawal migraine. II. Attempted prophylaxis by continuous estradiol administration. Neurology 1975;25:245-250
33. Rasmussen BK. Migraine and tension-type headache in a general population: precipitating factors, female hormones, sleep pattern and relation to lifestyle. Pain 1993;53: 65-72
34. Passchier J, Kaminsky MM, Paarlberg KM, van Geijn HP. Stress during pregnancy is unrelated to headache change in migraineurs. Headache 1996;36:189
35. Granella F, Sances G, Pucci E, Nappi RE, Ghiotto N, Napp G. Migraine with aura and reproductive life events: a case control study. Cephalalgia 2000;20:701-707
36. Scharff L, Marcus DA, Turk DC. Headache during pregnancy and in the postpartum: a prospective study. Headache 1997; 37:203-210
37. Lo WY, Friedman JM. Teratogenicity of recently introduced medications in human pregnancy. Obstet Gynecol 2002;100: 465-473
38. Pregnancy categories for prescription drugs. FDA Drug Bull 1982;12:24-25
39. Boothby LA, Doering PL. FDA labeling system for drugs in pregnancy. Ann Pharmacother 2001;35:1485-1489
40. Friedman JM, Little BB, Brent RL, Cordero JF, Hanson JW, Shepard TH. Potential human teratogenicity of frequently prescribed drugs. Obstet Gynecol 1990;75:594-599
41. Addis A, Sharabi S, Bonati M. Risk classification systems for drug use during pregnancy: are they a reliable source of information? Drug Saf 2000;23:245-253
42. Loder E. Safety of sumatriptan in pregnancy: a review of the data so far. CNS Drugs 2003;17:1-7
43. Feniuk W, Humphrey PP, Perren MJ. GR43175 does not share the complex pharmacology of the ergots. Cephalalgia 1989;9(suppl 9):35-39
44. Acs N, Banhidy F, Puho E, Czeizel AE. A possible dose-dependent teratogenic effect of ergotamine. Reprod Toxicol 2006;22:551-552
45. Smets K, Zecic A, Willems J. Ergotamine as a possible cause of Möbius sequence: additional clinical observation. J Child Neurol 2004;19:398
46. Hosking SP. Ergotamine use in pregnancy. Aust N Z J Obstet Gynaecol 1996;36:159-160
47. Raymond GV. Teratogen update: ergot and ergotamine. Teratology 1995;51:344-347
48. Needs CJ, Brooks PM. Antirheumatic medication in pregnancy. Br J Rheumatol 1985;24:282-290
49. Hermes-DeSantis ER, Clyman RI. Patent ductus arteriosus: pathophysiology and management. J Perinatol 2006;26(suppl 1): S14-S18; discussion S22-S23
50. Ostrea EM Jr. Neonatal withdrawal from intrauterine exposure to butalbital. Am J Obstet Gynecol 1982;143: 597-598
51. Reinisch JM, Sanders SA, Mortensen EL, Rubin DB. In utero exposure to phenobarbital and intelligence deficits in adult men. JAMA 1995;274:1518-1525
52. Holmes LB, Coull BA, Dorfman J, Rosenberger PB. The correlation of deficits in IQ with midface and digit hypoplasia in children exposed in utero to anticonvulsant drugs. J Pediatr 2005;146:118-122
53. Yao M, Ritchie HE, Brown-Woodman PD. A reproductive screening test of feverfew: is a full reproductive study warranted? Reprod Toxicol 2006;22:688-693
54. Buckner KD, Chavez ML, Raney EC, Stoehr JD. Health food stores recommendations for nausea and migraines during pregnancy. Ann Pharmacother 2005;39:274-279
55. Allena M, Magis D, Schoenen J. A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines. Neurology 2005;65:1339-1340
56. Shrim A, Boskovic R, Maltepe C, Navios Y, Garcia-Bournissen F, Koren G. Pregnancy outcome following use of large doses of vitamin B6 in the first trimester. J Obstet Gynaecol 2006;26:749-751
57. Thaver D, Saeed MA, Bhutta ZA. Pyridoxine (vitamin B6) supplementation in pregnancy. Cochrane Database Syst Rev 2006;(2):CD000179
58. Einarson A, Maltepe C, Navioz Y, Kennedy D, Tan MP, Koren G. The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study. BJOG 2004; 111:940-943
59. Bsat FA, Hoffman DE, Seubert DE. Comparison of three outpatient regimens in the management of nausea and vomiting in pregnancy. J Perinatol 2003;23:531-535
60. Gur C, Diav-Citrin O, Shechtman S, Arnon J, Ornoy A. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study. Reprod Toxicol 2004;18:93-101
61. Crowther CA, Harding J. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. Cochrane Database Syst Rev 2003;(3):CD003935
62. Leung TN, Lam PM, Ng PC, Lau TK. Repeated courses of antenatal corticosteroids: is it justified? Acta Obstet Gynecol Scand 2003;82:589-596
63. Pfaffenrath V, Rehm M. Migraine in pregnancy: what are the safest treatment options? Drug Saf 1998;19:383-388
64. Buchanan TM, Ramadan NM. Prophylactic pharmacotherapy for migraine headaches. Semin Neurol 2006;26:188-198
65. Marcus DA. Pregnancy and chronic headache. Expert Opin Pharmacother 2002;3:389-393
66. Scharff L, Marcus DA, Turk DC. Maintenance of effects in the nonmedical treatment of headaches during pregnancy. Headache 1996;36:285-290
67. Marcus DA, Scharff L, Turk DC. Nonpharmacological management of headaches during pregnancy. Psychosom Med 1995;57:527-535
68. Sandor PS, Afra J. Nonpharmacologic treatment of migraine. Curr Pain Headache Rep 2005;9:202-205
69. Wall VR. Breastfeeding and migraine headaches. J Hum Lact 1992;8:209-212
70. Sances G, Granella F, Nappi RE, et al. Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia 2003;23:197-205
71. American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics 2001;108:776-789
72. Wojnar-Horton RE, Hackett LP, Yapp P, Dusci LJ, Paech M, Ilett KF. Distribution and excretion of sumatriptan in human milk. Br J Clin Pharmacol 1996;41:217-221
73. Goldszmidt E, Kern R, Chaput A, Macarthur A. The incidence and etiology of postpartum headaches: a prospective cohort study. Can J Anaesth 2005;52:971-977
74. Stein G, Morton J, Marsh A, et al. Headaches after childbirth. Acta Neurol Scand 1984;69:74-79
75. Marcus DA, Scharff L, Turk D. Longitudinal prospective study of headache during pregnancy and postpartum. Headache 1999;39:625-632
76. Granella F, Sances G, Zanferrari C, Costa A, Martignoni E, Manzoni GC. Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache 1993;33:385-389
77. Campos CR, Yamamoto FI. Intracerebral hemorrhage in postpartum cerebral angiopathy associated with the use of isometheptene. Int J Gynaecol Obstet 2006;95:151-152
78. Sato S, Shimizu M, Endo K, Homma M, Yamamoto T. Postpartum cerebral angiopathy-a case report the vasculopathy associated with co-administration of two vasoconstrictives, methylergometrine maleate and sumatriptan. Rinsho Shinkeigaku 2004;44:96-101
79. Granier I, Garcia E, Geissler A, Boespflug MD, Durand-Gasselin J. Postpartum cerebral angiopathy associated with the administration of sumatriptan and dihydroergotamine: a case report. Intensive Care Med 1999;25:532-534
80. Raroque HG Jr, Tesfa G, Purdy P. Postpartum cerebral angiopathy. Is there a role for sympathomimetic drugs? Stroke 1993;24:2108-2110
81. Iffy L, Zito GE, Jakobovits AA, Ganesh V, McArdle JJ. Postpartum intracranial haemorrhage in normotensive users of bromocriptine for ablactation. Pharmacoepidemiol Drug Saf 1998;7:167-171
82. Oliver CD, White SA. Unexplained fitting in three parturients suffering from postdural puncture headache. Br J Anaesth 2002;89:782-785